As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Eli Lilly CEO confirms oral obesity drug Phase 3 results expected in Q2 Eli Lillys CEO updates on drug trials amid mixed ...

Tirzepatide works by activating receptors of hormones produced by the intestine to reduce hunger. It can result in weight loss, which may improve sleep apnea. Hypoglossal nerve stimulation is a ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...